How big is Talkspace, Inc.?

As of Jun 18, Talkspace, Inc. has a market capitalization of 476.85 million and reported net sales of 194.36 million with a net profit of 2.93 million over the latest four quarters. The balance sheet shows shareholder's funds of 117.39 million and total assets of 212.82 million.

As of Jun 18, Talkspace, Inc. has a market capitalization of 476.85 million, classified as a Micro Cap.<BR><BR>As of Jun 18, the company reported net sales of 194.36 million for the latest four quarters and a net profit of 2.93 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 117.39 million and total assets of 212.82 million.

What does Talkspace, Inc. do?

Talkspace, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $52 million and a market cap of $476.85 million. It has a P/E ratio of 188.00 and no dividend yield.

Overview:<BR>Talkspace, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 52 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 476.85 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 188.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.96 <BR>Return on Equity: 2.59% <BR>Price to Book: 4.20 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Should I buy, sell or hold Talkspace, Inc.?

Is Talkspace, Inc. overvalued or undervalued?

As of October 31, 2025, Talkspace, Inc. is considered overvalued with a high P/E ratio of 188 and negative EV to EBITDA, despite short-term outperformance against the S&P 500, indicating a valuation grade shift from very attractive to attractive.

As of 31 October 2025, the valuation grade for Talkspace, Inc. has moved from very attractive to attractive. The company appears to be overvalued, particularly given its high P/E ratio of 188, which is significantly above the peer average of 156.07, and its negative EV to EBITDA of -170.31, indicating substantial operational challenges. Additionally, the PEG ratio stands at 1.51, suggesting that the stock may not be justified by its growth prospects.<BR><BR>In comparison to its peers, Fulgent Genetics, Inc. has a P/E of -21.28, while Enhabit, Inc. has a P/E of 12.80, both indicating that Talkspace is trading at a premium despite its negative financial metrics. The stock has outperformed the S&P 500 in the short term, with a 3-year return of 429.14% compared to the S&P 500's 76.66%, but it has underperformed over the longer term, with a 5-year return of -65.53% versus the S&P 500's 109.18%. This mixed performance further supports the conclusion that Talkspace is currently overvalued.

Is Talkspace, Inc. technically bullish or bearish?

As of October 31, 2025, Talkspace, Inc. exhibits a neutral trend with mixed signals, showing bullish MACD indicators but bearish RSI on the weekly, while outperforming the S&P 500 recently, suggesting caution in a sideways market.

As of 31 October 2025, the technical trend for Talkspace, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD is bullish on both weekly and monthly time frames, while the RSI indicates a bearish signal on the weekly but shows no signal on the monthly. Moving averages are mildly bearish on the daily, and both KST and Bollinger Bands present a bullish signal on the weekly, with Bollinger Bands showing sideways movement on the monthly. Dow Theory indicates no trend in both weekly and monthly periods.<BR><BR>In terms of performance, Talkspace has outperformed the S&P 500 over the past week and month, with returns of 22.71% and 21.38% respectively, but lags behind on a year-to-date and one-year basis. Overall, the mixed signals suggest caution as the stock navigates a sideways trend.